Expands Patient Access to Andexxa, the First and Only Antidote for Reversal of the Factor Xa Inhibitors Rivaroxaban or Apixaban –. – Full Commercial Launch to ...
Thromboelastography TEG Analyzer Liver Transplant Cardiac Surgery India TEG 5000 TEMA ROTEM MONOTEMA Platelet Mapping Thromboelastograph www.thromboelastography.com Thromboelastogram Hemostasis Management
Monday, 31 December 2018
U.S. Food and Drug Administration Approves Portola Pharmaceuticals' Prior Approval Supplement for Andexxa® Generation 2 Manufacturing Process - P&T Community
U.S. Food and Drug Administration Approves Portola Pharmaceuticals' Prior Approval Supplement for Andexxa® Generation 2 Manufacturing Process P&T Community
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment